» Articles » PMID: 39193525

Lutein Inhibits Glutamate-induced Apoptosis in HT22 Cells Via the Nrf2/HO-1 Signaling Pathway

Overview
Journal Front Neurosci
Date 2024 Aug 28
PMID 39193525
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Excessive glutamate levels induce oxidative stress, resulting in neuronal damage, and cell death. While natural antioxidants show promise for neuroprotection, their effectiveness in the central nervous system (CNS) is limited by the blood -brain barrier. Lutein, a neuroprotective carotenoid, has gained attention for its ability to traverse this barrier and accumulate in various brain regions. This study aimed to elucidate the mechanisms underlying the protective effects of lutein against glutamateinduced cell death in HT22 cells.

Methods: HT22 cells were treated with lutein (1.25-20 μM) for 24 hours. Cell viability, ROS levels, apoptosis, and mitochondrial membrane potential were assessed following lutein pretreatment and glutamate exposure. Protein expression of apoptotic markers was analyzed using Western blotting.

Results: Lutein effectively attenuated glutamate-induced apoptosis due to its antioxidant properties. Additionally, lutein inhibited glutamate-induced mitochondrial-mediated apoptosis. We observed that lutein modulated the nuclear translocation of nuclear factor erythroid 2 -related factor 2 (Nrf2) and upregulated the expression of heme oxygenase-1 (HO-1). Inhibition of HO-1 by tin protoporphyrin (SnPP), a synthetic inhibitor, weakened the protective effect of lutein. Furthermore, we demonstrated that lutein prevented the aberrant activation of MAPKs induced by glutamate, including ERK1/2, p38, and JNK, thereby conferring oxidative protection.

Discussion: Our study highlights the potent antioxidant properties of lutein, which effectively safeguards against glutamate-induced mitochondrial apoptotic cell death through the Nrf2/HO-1 signaling pathway and inhibition of MAPK activation. These findings demonstrate that lutein exerts a neuroprotective effect against glutamate-induced neuronal cell damage.

References
1.
Cuadrado A, Rojo A, Wells G, Hayes J, Cousin S, Rumsey W . Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019; 18(4):295-317. DOI: 10.1038/s41573-018-0008-x. View

2.
Fukui M, Song J, Choi J, Choi H, Zhu B . Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells. Eur J Pharmacol. 2009; 617(1-3):1-11. DOI: 10.1016/j.ejphar.2009.06.059. View

3.
Stanciu M, Wang Y, Kentor R, Burke N, Watkins S, Kress G . Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem. 2000; 275(16):12200-6. DOI: 10.1074/jbc.275.16.12200. View

4.
Kim H, Lim S, Park I, Lim J, Seo J, Kim J . Neuroprotective effects of dehydroglyasperin C through activation of heme oxygenase-1 in mouse hippocampal cells. J Agric Food Chem. 2012; 60(22):5583-9. DOI: 10.1021/jf300548b. View

5.
Agarwal P, Wang Y, Buchman A, Holland T, Bennett D, Morris M . Dietary antioxidants associated with slower progression of parkinsonian signs in older adults. Nutr Neurosci. 2020; 25(3):550-557. PMC: 7680274. DOI: 10.1080/1028415X.2020.1769411. View